These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36286721)

  • 1. [Advantages of the use of metformin in patients with impaired uric acid metabolism].
    Eliseev MS; Panevin TS; Zhelyabina OV; Nasonov EL
    Ter Arkh; 2021 May; 93(5):71520. PubMed ID: 36286721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout].
    Panevin TS; Eliseev MS; Shestakova MV; Nasonov EL
    Ter Arkh; 2020 Jun; 92(5):110-118. PubMed ID: 32598783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses.
    Dai H; Hou T; Wang Q; Zhu Z; Zhu Y; Zhao Z; Li M; Xu Y; Lu J; Wang T; Ning G; Wang W; Bi Y; Zheng J; Xu M
    Diabetes Obes Metab; 2024 Jan; 26(1):242-250. PubMed ID: 37807832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus.
    Davies MJ; Trujillo A; Vijapurkar U; Damaraju CV; Meininger G
    Diabetes Obes Metab; 2015 Apr; 17(4):426-9. PubMed ID: 25600248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus.
    Ahmadieh H; Azar S
    Diabetes Technol Ther; 2017 Sep; 19(9):507-512. PubMed ID: 28749169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperuricemia and gout: diagnosis and therapy].
    Tausche AK; Unger S; Richter K; Wunderlich C; Grässler J; Roch B; Schröder HE
    Internist (Berl); 2006 May; 47(5):509-20; quiz 521. PubMed ID: 16586130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-Glucose Cotransporter-2 (SGLT-2) Attenuates Serum Uric Acid (SUA) Level in Patients with Type 2 Diabetes.
    Hussain M; Elahi A; Hussain A; Iqbal J; Akhtar L; Majid A
    J Diabetes Res; 2021; 2021():9973862. PubMed ID: 34239940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How PCP education can impact gout management: the gout essentials.
    Weaver AL; Cheh MA; Kennison RH
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S42-6. PubMed ID: 18830090
    [No Abstract]   [Full Text] [Related]  

  • 9. Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S19-26. PubMed ID: 21654266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin sensitizer and urate metabolism].
    Iwatani M; Wasada T; Iwamoto Y; Kamatani N
    Nihon Rinsho; 2000 Feb; 58(2):430-4. PubMed ID: 10707571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
    Takahashi T; Beppu T; Hidaka Y; Hosoya T
    Clin Exp Hypertens; 2021 Nov; 43(8):730-741. PubMed ID: 34425059
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of metformin on glucose metabolism in patients receiving glucocorticoids.
    Landis D; Sutter A; Fernandez F; Nugent K
    Am J Med Sci; 2022 Oct; 364(4):379-385. PubMed ID: 35525318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of phytotherapy of gout: perspective of new pharmacological treatments.
    Ling X; Bochu W
    Pharmazie; 2014 Apr; 69(4):243-56. PubMed ID: 24791587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis.
    Banerjee M; Pal R; Mukhopadhyay S
    Acta Diabetol; 2022 Jun; 59(6):783-791. PubMed ID: 35249140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout and hyperuricemia.
    Chilappa CS; Aronow WS; Shapiro D; Sperber K; Patel U; Ash JY
    Compr Ther; 2010; 36():3-13. PubMed ID: 21229813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
    Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease.
    Katsiki N; Dimitriadis GD; Mikhailidis DP
    Curr Pharm Des; 2021; 27(16):1941-1951. PubMed ID: 33397230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2015; 15(3):196-205. PubMed ID: 25772174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.